Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to -$681000.0.

  • Celularity's Net Cash Flow fell 20538.12% to -$681000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$76000.0, marking a year-over-year increase of 9840.57%. This contributed to the annual value of $814000.0 for FY2024, which is 10436.72% up from last year.
  • Celularity's Net Cash Flow amounted to -$681000.0 in Q3 2025, which was down 20538.12% from $632000.0 recorded in Q2 2025.
  • In the past 5 years, Celularity's Net Cash Flow ranged from a high of $64.5 million in Q3 2021 and a low of -$35.4 million during Q4 2021
  • Its 5-year average for Net Cash Flow is -$3.1 million, with a median of -$1.4 million in 2024.
  • Over the last 5 years, Celularity's Net Cash Flow had its largest YoY gain of 23006.63% in 2021, and its largest YoY loss of 752017.78% in 2021.
  • Celularity's Net Cash Flow (Quarter) stood at -$35.4 million in 2021, then grew by 18.9% to -$28.7 million in 2022, then surged by 82.79% to -$4.9 million in 2023, then soared by 113.09% to $646000.0 in 2024, then tumbled by 205.42% to -$681000.0 in 2025.
  • Its last three reported values are -$681000.0 in Q3 2025, $632000.0 for Q2 2025, and -$673000.0 during Q1 2025.